To treat insulin lipoatrophy, small amounts of dexamethasone (4 micrograms/unit) were added to insulin injections in nine patients. Six cases showed significant improvement of dexamethasone-treated sites over that of control sites in six months. With the continued use of dexamethasone-containing insulin, they remained mostly free of atrophie areas during the follow-up period of over two years. Our experience suggests the usefulness of this therapy.
Original Contributions| April 01 1977
Use of Dexamethasone in Treatment of Insulin Lipoatrophy
Dinesh Kumar, MD;
Leona V Miller, MD;
Dinesh Kumar, Leona V Miller, Suresh D Mehtalia; Use of Dexamethasone in Treatment of Insulin Lipoatrophy. Diabetes 1 April 1977; 26 (4): 296–299. https://doi.org/10.2337/diab.26.4.296
Download citation file: